Pharmafile Logo

dual tasking

- PMLiVE

Four Health announces a pair of internal promotions

Richard Springham and Kelly Smith will both take on managing director roles

Sanofi reception

FDA approves Sanofi’s key cancer drug Sarclisa for myeloma

First cancer drug wholly owned by company to be approved in past decade

- PMLiVE

Sandoz admits antitrust crime, pays $195m in penalties

Biggest payout in US legal history for this type of criminal activity

- PMLiVE

Shanks v Unilever? Or David v Goliath?

Could inventive employees be in line for a big pay-out?

- PMLiVE

Porterhouse Medical Group strengthens its leadership team in the US

The Porterhouse Medical Group is delighted to welcome Julia (Wenniger) Van Diver, who joins the team as Vice President, Scientific Services, at Porterhouse Medical US.Julia has a BA (Hons) in English...

Porterhouse Medical Group

- PMLiVE

FDA clears generic of Daraprim, the ‘poster drug’ for price-gouging

Drug hit headlines after price jumped from $13.50 to $750 overnight

- PMLiVE

Modest meeting sees only two drugs recommended by CHMP

Lilly’s migraine med Emgality receives negative opinion for label extension

- PMLiVE

GlaxoSmithKline reportedly looking to sell select antibiotic brands

Sale would fund R&D efforts in other key focus areas such as oncology

- PMLiVE

Gilead swoops on Forty Seven with $4.9bn all-cash deal

Takeover is latest in a string of billion-plus deals signed by Gilead

- PMLiVE

Biohaven gets FDA approval for migraine drug Nurtec ODT

Becomes second drugmaker to bring an oral CGRP inhibitor to US market

- PMLiVE

Boosting innovation in healthcare and scientific communications

It’s time for communications to be brave and bring the outside in

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links